X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23215) 23215
Newsletter (428) 428
Book Chapter (123) 123
Newspaper Article (107) 107
Magazine Article (86) 86
Dissertation (47) 47
Conference Proceeding (19) 19
Web Resource (10) 10
Publication (8) 8
Book / eBook (5) 5
Book Review (4) 4
Government Document (4) 4
Paper (2) 2
Streaming Video (2) 2
Transcript (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15831) 15831
ribavirin (12568) 12568
antiviral agents - therapeutic use (8701) 8701
male (8652) 8652
female (8334) 8334
hepatitis c, chronic - drug therapy (7572) 7572
ribavirin - therapeutic use (7371) 7371
hepatitis c (7309) 7309
middle aged (7072) 7072
adult (6419) 6419
gastroenterology & hepatology (6142) 6142
drug therapy, combination (5669) 5669
interferon (5653) 5653
hepatitis c virus (5386) 5386
interferon-alpha - therapeutic use (5102) 5102
treatment outcome (4806) 4806
hepacivirus - genetics (4235) 4235
genotype (3823) 3823
recombinant proteins (3495) 3495
therapy (3438) 3438
plus ribavirin (3289) 3289
infection (3185) 3185
antiviral agents - administration & dosage (3173) 3173
ribavirin - administration & dosage (3155) 3155
infectious diseases (3154) 3154
aged (3150) 3150
hepatitis c - drug therapy (3101) 3101
virology (2899) 2899
hepatitis (2885) 2885
polyethylene glycols - therapeutic use (2862) 2862
health aspects (2783) 2783
antiviral agents - adverse effects (2705) 2705
virus-infection (2624) 2624
hepatitis c, chronic - virology (2527) 2527
hepacivirus - drug effects (2488) 2488
pharmacology & pharmacy (2409) 2409
antiviral agents (2285) 2285
interferon-alpha - administration & dosage (2225) 2225
biological response modifiers (2117) 2117
care and treatment (2114) 2114
ribavirin - adverse effects (2090) 2090
hcv (2065) 2065
viral load (2064) 2064
animals (1886) 1886
drug therapy (1841) 1841
interferon-alpha - adverse effects (1821) 1821
virus diseases (1816) 1816
hepatitis c, chronic - complications (1812) 1812
antiviral agents - pharmacology (1797) 1797
pegylated interferon (1796) 1796
sustained virological response (1780) 1780
liver (1732) 1732
chronic hepatitis c (1707) 1707
viruses (1688) 1688
immunology (1671) 1671
analysis (1649) 1649
infections (1631) 1631
rna, viral - blood (1607) 1607
cirrhosis (1603) 1603
chronic hepatitis-c (1551) 1551
combination therapy (1522) 1522
risk factors (1487) 1487
virus (1472) 1472
ribavirin - pharmacology (1469) 1469
retrospective studies (1450) 1450
genetic aspects (1438) 1438
combination (1426) 1426
recombinant proteins - therapeutic use (1417) 1417
research (1415) 1415
microbiology (1392) 1392
medicine, general & internal (1377) 1377
peginterferon (1325) 1325
sofosbuvir (1296) 1296
time factors (1274) 1274
interferons - therapeutic use (1266) 1266
polyethylene glycols - administration & dosage (1260) 1260
peginterferon alpha-2a (1209) 1209
rna (1199) 1199
adolescent (1178) 1178
interferon-alpha (1170) 1170
antiviral therapy (1158) 1158
genotypes (1157) 1157
hepacivirus - isolation & purification (1149) 1149
initial treatment (1149) 1149
patients (1133) 1133
young adult (1129) 1129
hiv (1116) 1116
efficacy (1093) 1093
recurrence (1090) 1090
transplantation (1090) 1090
hepatitis c - virology (1088) 1088
hepatitis c - complications (1085) 1085
hiv infections - complications (1077) 1077
gastroenterology and hepatology (1075) 1075
fibrosis (1065) 1065
prospective studies (1058) 1058
telaprevir (1039) 1039
hepatocellular-carcinoma (1003) 1003
liver cirrhosis (1003) 1003
prevalence (955) 955
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21843) 21843
French (401) 401
Spanish (388) 388
German (305) 305
Japanese (297) 297
Korean (200) 200
Russian (195) 195
Chinese (168) 168
Polish (110) 110
Portuguese (84) 84
Hungarian (67) 67
Czech (50) 50
Italian (50) 50
Turkish (35) 35
Croatian (20) 20
Serbian (14) 14
Dutch (13) 13
Danish (8) 8
Hebrew (6) 6
Finnish (5) 5
Slovak (5) 5
Swedish (5) 5
Arabic (3) 3
Bosnian (3) 3
Norwegian (3) 3
Persian (3) 3
Lithuanian (2) 2
Romanian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Catalan (1) 1
Icelandic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 17, pp. 1604 - 1614
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2014, Volume 147, Issue 2, pp. 359 - 365.e1
Background & Aims The interferon-free regimen of ABT-450 (a protease inhibitor), ritonavir, ombitasvir (an NS5A inhibitor), dasabuvir (a non-nucleoside... 
Gastroenterology and Hepatology | IFN | PEARL-II | Ribavirin-Free | Interferon-Free Therapy | PLUS RIBAVIRIN | ABT-450/R-OMBITASVIR | VIRUS-INFECTION | TELAPREVIR | SOFOSBUVIR | CHRONIC HEPATITIS-C | COMBINATION | TRIAL | CIRRHOSIS | BOCEPREVIR | GASTROENTEROLOGY & HEPATOLOGY | Anilides - therapeutic use | Puerto Rico | Hepatitis C - drug therapy | United States | Anilides - adverse effects | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Viral Load | Ritonavir - adverse effects | Time Factors | Ritonavir - therapeutic use | Adult | Female | Drug Therapy, Combination | Hepacivirus - drug effects | Antiviral Agents - therapeutic use | Europe | Ribavirin - therapeutic use | Uracil - therapeutic use | Genotype | Treatment Outcome | Macrocyclic Compounds - adverse effects | Biomarkers - blood | Macrocyclic Compounds - therapeutic use | Hepatitis C - diagnosis | Uracil - adverse effects | Sulfonamides - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Sulfonamides - adverse effects | Carbamates - adverse effects | Hepacivirus - growth & development | Aged | Carbamates - therapeutic use | Uracil - analogs & derivatives | Medical colleges | Care and treatment | Proteases | Ritonavir | Biological products industry | Genetic aspects | Biological response modifiers | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin
Journal Article
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 108 - 117
Background & Aims Interferon alfa–based regimens used to treat recurrent hepatitis C virus (HCV) infection after liver transplantation are poorly tolerated,... 
Gastroenterology and Hepatology | Antiviral Agent | Clinical Trial | DAA | NS5B Polymerase Inhibitor | PLUS RIBAVIRIN | MULTICENTER | ANTIVIRAL THERAPY | EFFICACY | HCV GENOTYPE 1 | GRAFT | COMBINATION | INTERFERON | DYSFUNCTION | GASTROENTEROLOGY & HEPATOLOGY | DRUG-DRUG INTERACTIONS | Recurrence | Prospective Studies | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Liver Transplantation - adverse effects | United States | Humans | Drug Resistance, Viral | Hepacivirus - genetics | Hepacivirus - pathogenicity | Male | RNA, Viral - blood | Viral Load | Time Factors | Ribavirin - pharmacokinetics | Female | Hepatitis C - complications | Uridine Monophosphate - adverse effects | Drug Therapy, Combination | Uridine Monophosphate - therapeutic use | Hepacivirus - drug effects | Liver Neoplasms - virology | Liver Cirrhosis - diagnosis | Antiviral Agents - therapeutic use | Carcinoma, Hepatocellular - diagnosis | Ribavirin - therapeutic use | Carcinoma, Hepatocellular - surgery | Genotype | Liver Neoplasms - surgery | Treatment Outcome | Carcinoma, Hepatocellular - virology | Biomarkers - blood | Spain | New Zealand | Hepatitis C - diagnosis | Pilot Projects | Liver Cirrhosis - virology | Liver Neoplasms - diagnosis | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Liver Cirrhosis - surgery | Uridine Monophosphate - pharmacokinetics | Sofosbuvir | Virus diseases | Relapse | Liver | Transplantation | Biological response modifiers | Drug therapy | Hepatitis C virus | Health aspects | Immunosuppressive agents | Ribavirin | Diseases
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 20, pp. 1867 - 1877
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 20, pp. 1878 - 1887
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158512
Background Ribavirin blood levels vary considerably between patients with standard weight-based dosing. Their impact on sustained virological response (SVR)... 
SUSTAINED VIROLOGICAL RESPONSE | THERAPY | POLYMORPHISMS | PREDICTOR | SOFOSBUVIR | MULTIDISCIPLINARY SCIENCES | PEGINTERFERON-ALPHA | GENOTYPE 2/3 INFECTION | HCV INFECTION | LEDIPASVIR | PLASMA-CONCENTRATION | Multivariate Analysis | Humans | Middle Aged | Male | Interferons - therapeutic use | Hepatitis C, Chronic - complications | Polyethylene Glycols - therapeutic use | Young Adult | Interleukins - genetics | Anemia - drug therapy | Ribavirin - administration & dosage | Adult | Female | Retrospective Studies | Drug Therapy, Combination | Ribavirin - blood | Antiviral Agents - blood | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polymorphism, Genetic | Anemia - complications | Immunosuppression | RNA, Viral | ROC Curve | Aged | Hepacivirus | Cohort Studies | Antiviral agents | Care and treatment | Anemia | Patient outcomes | Dosage and administration | Hepatitis C virus | Ribavirin | Transplants & implants | Liver | Viruses | Infections | Multivariate analysis | Gene polymorphism | Hepatitis | Hepatology | Human immunodeficiency virus--HIV | Gastroenterology | Hemoglobin | Drug dosages | Internal medicine | Regression analysis | Patients | Blood levels | Serum levels | Studies | Genotyping | Fibrosis | Interferon | Hepatitis C | Polymorphism | HIV | Human immunodeficiency virus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9742, pp. 705 - 716
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 135, Issue 2, pp. 451 - 458
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 360, Issue 18, pp. 1839 - 1850
Journal Article